What percent of DNA is sold short?

61.1% of Ginkgo (DNA) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is DNA a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for Ginkgo (DNA).

DNA Short Volume Hit 61.1%

$12.35

-0.15 (-1.20%)

Weekly Expected Move ±16.1%

$8 $10 $12 $14 $16

NYSE · Healthcare · Biotechnology · Tech Score Buy · Power 64 · $806.8M mcap · 48M float · 2.82% daily turnover · Short 60% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Short Volume Summary

2026-10-01

49.7%

Short Ratio

of total volume

59.3%

20-Day Avg

59.7%

50-Day Avg

▲ Rising

5-Day Trend

0.6M

Short Volume

1.2M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	555,502	1,100,018	50.5%
NYSE	52,477	113,701	46.2%
BATS	13,089	36,070	36.3%

DNA Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet